by Walter Gunzburg | Apr 1, 2023 | News, Press Release
This press release can be viewed online at: https://www.einnews.com/pr_news/625357967 SINGAPORE, SINGAPORE, March 31, 2023 /EINPresswire.com/– SGAustria (“Austrianova”), a leading provider of cell biological products and services, today announced details about...
by Walter Gunzburg | Mar 2, 2023 | News, Press Release
This press release can be viewed online at: https://www.einpresswire.com/article/619655265 Checkmate Capital makes preferred equity investment in Austrianova parent company SGAustria for GMP facility expansion SINGAPORE, March 1, 2023 /EINPresswire.com/ — SG...
by Walter Gunzburg | Feb 3, 2023 | News
We have shown the incredible physical robustness of Cell-in-a-Box® capsules placed under compression forces using a piston (see video) and also the stability of capsules when they are injected through a needle. Cell-in-a-Box® capsules are also stable for many...
by Walter Gunzburg | Dec 21, 2022 | News
Austrianova/SGAustria is pleased to announce that during the last year it has made major progress and achieved some significant milestones. During 2022, as well as our ongoing projects, the Company has acquired three new partners all involved in cutting edge therapy...
by Walter Gunzburg | Nov 29, 2022 | News
‘ ”’ ‘ All therapeutics go through three phasese of clinical trial testing (phase 1, 2 and 3) before market authorization is possible and they are approved for use in patients. Because late stage clinical trials involve more subjects than early...
